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Abstract
Aims. Intermittent explosive disorder (IED) is characterised by impulsive anger attacks that vary
greatly across individuals in severity and consequence. Understanding IED subtypes has been lim-
ited by lack of large, general population datasets including assessment of IED. Using the 17-coun-
try World Mental Health surveys dataset, this study examined whether behavioural subtypes of
IED are associated with differing patterns of comorbidity, suicidality and functional impairment.
Methods. IED was assessed using the Composite International Diagnostic Interview in the
World Mental Health surveys (n = 45 266). Five behavioural subtypes were created based
on type of anger attack. Logistic regression assessed association of these subtypes with lifetime
comorbidity, lifetime suicidality and 12-month functional impairment.
Results. The lifetime prevalence of IED in all countries was 0.8% (S.E.: 0.0). The two subtypes
involving anger attacks that harmed people (‘hurt people only’ and ‘destroy property and hurt
people’), collectively comprising 73% of those with IED, were characterised by high rates of exter-
nalising comorbid disorders. The remaining three subtypes involving anger attacks that destroyed
property only, destroyed property and threatened people, and threatened people only, were char-
acterised by higher rates of internalising than externalising comorbid disorders. Suicidal behav-
iour did not vary across the five behavioural subtypes but was higher among those with (v. those
without) comorbid disorders, and among those who perpetrated more violent assaults.
Conclusions. Themost common IED behavioural subtypes in these general population samples are
associatedwithhighratesof externalisingdisorders.This contrastswith the findings fromclinical stud-
ies of IED, which observe a preponderance of internalising disorder comorbidity. This disparity in
findings across population and clinical studies, together with the marked heterogeneity that charac-
terises the diagnostic entity of IED, suggests that it is a disorder that requires much greater research.
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Introduction
A prominent bimodal conceptualisation of aggression classifies
it as either: (i) spontaneous (referred to as reactive or impulsive
aggression), or (ii) planned (referred to as proactive, preme-
diated or instrumental aggression) (Babcock et al., 2014;
Wrangham, 2018). Impulsive aggression has generally been
found to be more characteristic of clinical samples and premedi-
tated aggression more characteristic of delinquent or criminal
populations (Jensen et al., 2007). The essential feature of inter-
mittent explosive disorder (IED) as defined in both DSM-IV
and DSM-5 is the occurrence of repeated episodes of impulsive
aggression resulting in verbal or physical assaults or property
destruction.
The first population studies on the epidemiology of DSM-IV
IED in the USA were undertaken using the World Mental
Health (WMH) surveys version of the Composite
International Diagnostic Interview (WMH-CIDI) (Kessler
et al., 2006; McLaughlin et al., 2012). In the National
Comorbidity Survey Replication (NCS-R), IED prevalence
among adults (18 years or older) based on a ‘broad’ definition
of IED requiring three or more impulsive anger attacks in the
lifetime was estimated to be 7.3%, decreasing to 5.4% based
on a ‘narrow’ definition requiring three or more anger attacks
in the same year (Kessler et al., 2006). In response to reviewer
feedback, the WMH-CIDI diagnostic algorithm was subse-
quently modified to further require that anger attacks should
cause at least some degree of interference with respondents’
work, social life or relationships, thus bringing the diagnosis
of IED into line with the other WMH-CIDI DSM-IV diagnoses.
We refer to this revised algorithm as the ‘conservative’ defin-
ition of IED, and we applied it in our first cross-national report
on IED which found lifetime prevalence ranging across coun-
tries from 0.1% to 2.7% with a weighted average of 0.8%
(Scott et al., 2016, 2018). The sociodemographic correlates of
lifetime risk of IED were being male, young, unemployed,
divorced or separated and having less education. The median
age of onset of IED was 17 and prior traumatic experiences
involving physical (non-combat) or sexual violence were asso-
ciated with increased risk of IED onset (Scott et al., 2016, 2018).
That earlier cross-national study focused on IED as a single
diagnostic entity; the present study focuses on IED subtypes.
It is a notable feature of IED as defined in DSM-IV and
DSM-5 that the aggressive outbursts potentially classifiable as
IED span a wide spectrum from non-destructive (verbal only)
through destruction of property to hurting people. This gives
rise to the possibility that IED could be characterised by distinct
behavioural subtypes, and although few studies have investigated
this, one study did find that comorbidity patterning varied by
DSM-5 IED subtypes (verbal aggression only, physical aggres-
sion only, or both) (Look et al., 2015). In the WMH surveys,
we have a sufficiently large number of respondents diagnosed
with IED to be able to classify IED subtypes according to the
type of aggressive behaviour. In this study, we use the same con-
servative definition of IED applied in our earlier cross-national
report, and we have created five mutually exclusive behavioural
subtypes. Our research questions were: (i) whether these behav-
ioural subtypes would be predominantly associated with differ-
ent types of comorbid mental disorder; and (ii) whether they




This study uses data from all WMH surveys that measured IED
(online Supplementary Table S1). A stratified multi-stage clus-
tered area probability sampling strategy was used to select adult
respondents (18 years+) in most WMH countries. In most coun-
tries, internal subsampling was used to reduce respondent burden
and average interview time by dividing the interview into two
parts. All respondents completed Part 1, which included the
core diagnostic assessment of mood disorders, most anxiety dis-
orders, substance use disorders and IED, and also assessed suicid-
ality and sociodemographics. All Part 1 respondents who met
lifetime criteria for any mental disorder and a probability sample
of respondents without mental disorders were administered Part
2, which assessed post-traumatic stress disorder, eating disorders,
childhood impulse-control disorders, psychotic symptoms, phys-
ical health, functional impairment, psychological distress, child-
hood adversities and service use. Part 2 respondents were
weighted by the inverse of their probability of selection for Part
2 of the interview to adjust for differential sampling. Additional
weights were used to adjust for differential probabilities of selec-
tion within households, to adjust for non-response and to match
the samples to population sociodemographic distributions. All
respondents provided written informed consent and measures
taken to ensure data accuracy, cross-national consistency and pro-
tection of respondents are described in detail elsewhere (Kessler
and Ustun, 2004, 2008).
Measures
Intermittent explosive disorder
All surveys used the WMH survey version of the WHO
Composite International Diagnostic Interview (CIDI 3.0)
(Kessler and Ustun, 2004), a fully structured, lay-administered,
face-to-face interview, to assess lifetime history of DSM-IV men-
tal disorders. DSM-IV Criterion A for IED requires ‘several dis-
crete episodes of failure to resist aggressive impulses that result
in serious assaultive acts or destruction of property’. This was
operationalised in the CIDI by requiring the respondent to report
at least three attacks in the same year of at least one of three types
of anger attacks: (i) ‘when all of a sudden you lost control and
broke or smashed something worth more than a few dollars’;
(ii) ‘when all of a sudden you lost control and hit or tried to
hurt someone’; and (iii) ‘when all of a sudden you lost control
and threatened to hit or hurt someone’. A 12-month diagnosis
was assigned if those meeting lifetime criteria reported at least
three attacks in the past 12 months.
DSM-IV criterion B for IED requires that the aggressiveness is
‘grossly out of proportion to any precipitating psychosocial stres-
sor’. This criterion was operationalised in the CIDI by requiring
the respondent to report either that they ‘got a lot more angry
than most people would have been in the same situation’ or
that the attacks occurred ‘without good reason’ or ‘in situations
where most people would not have had an anger attack’.
DSM-IV criterion C for IED requires that the ‘aggressive epi-
sodes are not better accounted for by another mental disorder and
are not due to the direct physiological effects of a substance or a
general medical condition’. This was assessed through a series of
questions (see (Kessler et al., 2006) for details) that ruled out IED
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diagnosis if anger attacks occurred exclusively when respondents
had been drinking or using drugs, when they were in a depressive
or manic episode, or as a consequence of an organic cause such as
epilepsy, head injury or use of medications.
In this paper, we have applied the conservative definition of
IED, requiring that respondents reported that their anger attacks
caused at least some degree of interference with their work, social
life or relationships. This is the same diagnostic algorithm used in
our recent cross-national reports (Scott et al., 2016, 2018).
DSM-IV v. DSM-5 criteria
DSM-5 criteria recognise two different patterns of the aggressive out-
burst: high frequency/low intensity (criterion A1: non-destructive
verbal or physical aggression occurring at least twice weekly for at
least three months) or low frequency/high intensity (criterion A2:
at least three destructive outbursts within a year-long period)
(Coccaro et al., 2014). The diagnostic algorithm used in the present
study requires three aggressive outbursts within 1 year, but as noted
in our earlier paper (Scott et al., 2016) there was insufficient infor-
mation on the lifetime frequency of specific types of aggressive out-
burst to confirm whether those meeting the DSM-IV criteria
operationalised in this study would also meet DSM-5 criteria.
IED subtypes
IED subtypes were mutually exclusive categories based on the type
of behaviour during anger attacks. The CIDI screening questions for
IED are based on the assumption that hurting other people is inher-
ently threatening. Therefore, all respondents are asked whether they
have ever in their life ‘had attacks of anger when all of a sudden
[they] lost control and broke or smashed something worth more
than a few dollars’ and whether they have ever ‘had attacks of
anger when all of a sudden [they] lost control and hit or tried to
hurt someone’. However, only respondents who answer ‘no’ to
this second question are asked whether they have ever ‘had attacks
of anger when all of a sudden [they] lost control and threatened to
hit or hurt someone’. Given this skip logic in the CIDI, the number
of possible subtypes is 5. Subtype 1 consisted of people whose anger
attacks destroyed property only; subtype 2 consisted of people
whose anger attacks threatened people only; subtype 3 consisted
of people whose anger attacks hurt people but not property (with
or without threatening); subtype 4 destroyed property and threa-
tened people; subtype 5 destroyed property and hurt people.
Impairment and suicidality
The assessment of impairment included questions about lifetime
impairment as well as impairment in the past 12 months. The
lifetime questions were asked about the financial value of all the
things the respondent ever broke or damaged during an anger
attack and the number of times either the respondent or someone
else had to seek medical attention because of an injury caused by
one of the respondent’s anger attacks. The 12-month questions
asked respondents to rate the extent to which their symptoms
interfered with their lives and activities in the worst month of
the past year using the Sheehan Disability Scales (Leon et al.,
1997). These are 0–10 visual analogue scales that ask how much
a focal disorder interfered with home management, work, social
life and personal relationships using the response options none
(0), mild (1–3), moderate (4–6), severe (7–10). All respondents
were asked whether in their lifetime they had ever seriously
thought about committing suicide, and, if so, whether they had
ever made a plan or attempted suicide.
Statistical analysis
Cross-tabulation was used to determine the prevalence of IED
and its subtypes. We used logistic regression to examine the asso-
ciation between IED (subtypes) and lifetime comorbidity, lifetime
suicidality and 12-month impairment due to IED. Logistic regres-
sion was also used to examine the association between the severity
of IED-related violence and these outcomes. All analyses con-
trolled for the country of origin of the participant, as well as par-
ticipant’s sex, age and educational attainment. Because the data
were clustered and weighted, standard errors were estimated
using the Taylor series linearisation method (SUDAAN 11.0.1).
Results
Prevalence of IED and its subtypes
Table 1 shows that the overall lifetime prevalence of IED in all
countries was 0.8%. The table also shows the prevalence of the
five behavioural subtypes. The most common subtype, with a
prevalence of 0.4%, was the subtype with the most severe conse-
quences, involving anger attacks that both destroy property and
hurt people. The next most common subtype (‘hurt people
only’: 0.2%) involves acts of aggression that result in people
(but not property) being hurt. The other three subtypes are char-
acterised by acts of aggression that do not result in harm to per-
sons and these were the lowest prevalence, at around 0.1% each.
Lifetime comorbidity
The pattern of lifetime comorbidity among those with IED is
shown in Table 2, with people without IED (including those with-
out any disorder) as the reference group. Comorbidity rates were
high, with 80.5% of those with IED having at least one comorbid
disorder, with anxiety disorders being the largest disorder class
(55.1%). The percentages reflect, in part, the base rate of the dis-
orders; the odds ratios provide information about the relative like-
lihood of specific types of comorbidity disorders after taking the
base rate into account. From the column of odds ratios we see that
internalising disorders were highly comorbid with IED (OR: 7.4;
95% CI: 5.8–9.5); this reflects the high comorbidity with anxiety
disorders as a class (OR: 7.2; 95% CI: 5.8–8.8) and with bipolar
disorder (OR: 6.8; 95% CI: 5.1–8.9). But there was not high
comorbidity with mood disorders as a class, and indeed depres-
sion was the specific disorder with the lowest odds of comorbidity
with IED (OR: 2.7; 95% CI: 2.1–3.5).
There was also high comorbidity with externalising disorders
as a class (OR: 7.0; 95% CI: 5.6–8.8), due in particular to high
comorbidity with the class of disruptive behaviour disorders
(OR: 6.9; 95% CI: 5.2–9.3) and with alcohol dependence (OR:
7.0; 95% CI: 5.0–9.8).
In analyses that investigated the temporal ordering of IED and
comorbid disorders we found that IED first developed following
the onset of the comorbid disorder/s in 61% of cases; conversely,
IED was the first disorder to occur in only 29% of cases and first
developed concurrently with another disorder 10% of the time.
(online Supplementary Table S2).
Lifetime comorbidity by IED subtype
Next, we analysed how comorbidity varied by the five IED sub-
types, with ‘No IED’ as the reference group (Table 3). The likeli-
hood of having any comorbid disorder (final row of the table) was
Epidemiology and Psychiatric Sciences 3
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highest amongst the subtype whose behaviour resulted in the least
destruction (’threaten people only’: OR: 14.6; 95% CI: 5.2–41.3),
followed by the subtype whose behaviour resulted in the most
destruction (‘destroy property and hurt people’: OR: 11.7; 95%
CI: 7.5–18.2). The two subtypes characterised by destruction of
property but not harm to people had the least likelihood of a
comorbid disorder (‘destroy property and threaten people’: OR:
6.6; 95% CI: 2.0–21.2; and ‘destroy property only’: OR: 6.0; 95%
CI: 3.3–11.0).
In terms of the pattern of comorbidity, the two subtypes that
involved hurting people (‘destroy property and hurt people’ and
‘hurt people only’) had a substantially higher likelihood of an
externalising comorbid disorder than the other three subtypes.
The least severe subtype (‘threaten people’) was much more likely
to have internalising than externalising comorbid disorders, with
an especially high odds of social phobia (OR: 13.3; 95% CI: 7.0–
25.1). It is also noteworthy that the two subtypes that involved
threatening people (‘destroy and threaten’; ‘threaten people’)
had the highest odds of bipolar disorder (OR: 10.0; 95% CI:
4.5–22.5 and OR: 11.3; 95% 3.2–39.9, respectively), although con-
fidence intervals around these (and many of the other) estimates
are wide.
Lifetime comorbidity by severity of violence to others
The next analysis (Table 4) subdivided those with IED into two
different groups according to the severity of their violence towards
others: (i) those who reported that they had hurt someone so
badly they needed medical attention and (ii) all the remaining
respondents with IED (reference group). Those whose anger
attacks resulted in others needing medical attention were both
more likely to have disorder comorbidity overall (OR for any dis-
order: 2.0; 95% CI: 1.0–4.1) and substantially more likely to have
disruptive behaviour disorder (OR: 2.7; 95% CI: 1.5–4.8) and sub-
stance use disorder (OR: 2.6; 95% CI: 1.6–4.2) comorbidity rela-
tive to the reference group whose violence was less severe. Rates
of internalising disorders were fairly similar across the two groups.
Suicidality
Lifetime suicidal behaviour amongst the total group with IED was
38.1% (S.E.: 2.0) for ideation, 17.6% (S.E.: 1.6) for plan and 17.4%
(S.E.: 1.4) for an attempt (online Supplementary Table S3a). When
subdividing total IED into those with and without lifetime
comorbidity, suicidal behaviour was much lower among the
group without comorbidity, with rates of 26.1% (S.E.: 6.3), 3.5%
(S.E.: 1.7) and 6.6% (S.E.: 2.4) for ideation, plans and attempts,
respectively, compared with corresponding percentages of 40.9%
(S.E.: 2.5), 20.5% (S.E.: 1.9) and 19.4% (S.E.: 1.8) in the group
with comorbidity (online Supplementary Table S3b).
There were no statistically significant differences in the preva-
lence of suicidal behaviour among the five behavioural subtypes
(online Supplementary Table S4). When we compared suicidal
behaviour between those who did, v. those who did not, hurt
someone so badly they needed medical attention, the former
group reported significantly more suicidal behaviour than the lat-
ter group, in all three suicidal behaviour categories (Table 5).
Impairment
The proportion of all those with 12-month IED who reported
severe functional impairment in at least one domain (home man-
agement, work, close relationships or social life) was 39.8% (S.E.:
3.0); with 44.1% (S.E.: 3.7) among those with comorbidity and
17.1% (S.E.: 6.4) among those without comorbidity (data not
shown, available on request). The proportion with severe impair-
ment ranged from 30.9% to 44.5% across the five behavioural sub-
types (online Supplementary Table S5); although these differences
were not statistically significant.
Discussion
In our first cross-national paper on IED (Scott et al., 2016), we
examined lifetime prevalence of comorbid mental disorders
among those with IED; the present study builds on that earlier
report by examining associations (rather than prevalence) of
IED with other lifetime disorders and by investigating whether
comorbidity patterns vary by IED behavioural subtypes. The
two IED subtypes characterised by acts of aggression resulting
in harm to others (collectively comprising 73% of those meeting
diagnostic criteria with IED) had a greater likelihood of externa-
lising disorder comorbidity than the other three subtypes,
although internalising disorder comorbidity was also prevalent.
The least destructive subtype (’threaten only’) had a much higher
odds of internalising (v. externalising) disorder comorbidity and
high odds of social phobia in particular. After further subdividing
those with IED into perpetrators of more v. less violent attacks, we
found that the more violent group were more likely to have CD,
ODD and substance use disorder comorbidity relative to the
less violent group. This more violent group also reported higher
rates of lifetime suicidal behaviour (ideation, plans and attempts).
There were no significant patterns of variation in functional
impairment across IED subtypes.
The major limitations of this study lie in its retrospective
assessment of mental disorders. This is known to underestimate
lifetime mental disorders (Moffitt et al., 2010; Takayanagi et al.,
2014) and to lead to inaccuracies in the age of onset timing
(Simon and Von Korff, 1995). The retrospective method is likely
to make it difficult for respondents to determine whether their
anger attacks did or did not occur in the context of other disor-
ders. This is a problem because IED is a diagnosis of exclusion,






651 86 789 0.8 0.04
IED – destroy property only 72 86 789 0.1 0.01
IED – threaten people only 54 86 789 0.1 0.01
IED – hurt people only (with/
without threatening)
118 86 789 0.2 0.02
IED – destroy property and
threaten people
52 86 789 0.1 0.01
IED – destroy property and hurt
people
355 86 789 0.4 0.03
Overall prevalence does not equal the sum of the prevalence of subtypes due to rounding.
Narrow IED is defined as hierarchical IED, with the added criteria that the respondent must
have had three or more attacks in a single year at least once and that the respondent
reports that the anger attacks interfere with work, social life, or personal relationships to at
least some degree.
IED subtypes are based on behaviour during anger attacks. Respondents were asked
whether they ever destroyed property or hurt people during an anger attack. If they reported
never having hurt someone, they were asked whether they had ever threatened to hurt
someone.
aNominator N (number of participants reporting the outcome).
bDenominator N (number of participants asked the question).
cPercentages are based on weighted data.
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Table 2. Lifetime prevalence of mental disorders in respondents with or without IED
Respondents without IED Respondents with IED Statistical test
Comorbid disorder n1
a n2
b %c S.E. n1
a n2
b %c S.E. OR (95% CI) Wald X2 p-value df
Agoraphobia (with or without panic) 1203 44 651 2.0 0.1 60 615 8.9 1.2 3.7* (2.7–5.1) 71.2* <0.001 1
Generalised anxiety disorder 2672 44 651 3.5 0.1 128 615 20.9 2.1 6.6* (5.0–8.7) 179.4* <0.001 1
Panic disorder (with or without agoraphobia) 1200 44 651 1.6 0.1 77 615 9.6 1.2 4.6* (3.4–6.3) 95.9* <0.001 1
Post-traumatic stress disorder 1889 38 244 3.2 0.1 100 547 16.4 1.7 4.9* (3.8–6.3) 144.0* <0.001 1
Separation anxiety disorder 2057 26 309 5.4 0.2 123 433 28.3 2.3 4.5* (3.5–5.6) 153.8* <0.001 1
Social phobia 2533 44 651 3.6 0.1 145 615 23.4 2.0 4.9* (3.9–6.3) 169.9* <0.001 1
Specific phobia 4560 38 698 7.7 0.2 153 533 26.9 2.1 3.5* (2.8–4.4) 117.0* <0.001 1
Any anxiety disorder 8128 44 651 12.1 0.2 343 615 55.1 2.3 7.2* (5.8–8.8) 354.9* <0.001 1
Major depression or dysthymia (hierarchical) 7936 44 651 10.2 0.2 190 615 26.4 2.4 2.7* (2.1–3.5) 59.2* <0.001 1
Bipolar disorder (broad) 1188 38 698 1.8 0.1 98 533 17.6 1.9 6.8* (5.1–8.9) 181.4* <0.001 1
Any mood disorder 9124 44 651 11.8 0.2 288 615 40.8 2.7 4.3* (3.4–5.5) 155.5* <0.001 1
Bulimia nervosa 203 17 105 0.7 0.1 12 254 4.4 1.5 5.5* (2.5–12.1) 18.6* <0.001 1
Binge eating disorder (hierarchical) 436 17 105 1.8 0.1 17 254 6.5 1.7 3.0* (1.7–5.2) 15.7* <0.001 1
Any eating disorder 598 17 105 2.3 0.1 29 254 10.9 2.3 4.2* (2.6–6.8) 35.0* <0.001 1
Any internalising disorder 13 487 44 651 19.0 0.3 435 615 67.1 2.6 7.4* (5.8–9.5) 251.7* <0.001 1
Attention deficit disorder 589 25 952 1.6 0.1 61 412 16.0 2.5 4.9* (3.2–7.6) 50.8* <0.001 1
Conduct disorder 652 21 666 2.2 0.1 84 376 23.8 2.8 6.3* (4.4–8.8) 111.2* <0.001 1
Oppositional defiant disorder 775 18 634 2.9 0.2 88 328 26.6 2.9 6.0* (4.2–8.6) 98.9* <0.001 1
Any disruptive behaviour disorder 1540 28 406 3.8 0.2 150 443 35.5 2.7 6.9* (5.2–9.3) 173.1* <0.001 1
Alcohol abuse 4136 42 226 8.1 0.2 208 565 38.4 2.4 5.6* (4.5–7.1) 222.4* <0.001 1
Alcohol dependence 1345 42 226 2.2 0.1 114 565 20.0 2.2 7.0* (5.0–9.8) 126.5* <0.001 1
Drug abuse 1236 40 187 2.4 0.1 101 544 17.2 2.0 4.3* (3.1–6.0) 74.4* <0.001 1
Drug dependence 447 40 187 0.8 0.1 56 544 9.7 1.4 5.7* (3.9–8.3) 80.4* <0.001 1
Any substance use disorder 4703 42 226 9.2 0.2 235 565 43.2 2.6 6.0* (4.8–7.6) 221.4* <0.001 1
Any externalising disorder 5629 44 651 10.2 0.2 301 615 50.5 2.4 7.0* (5.6–8.8) 304.7* <0.001 1
Any disorder 16 324 44 651 25.0 0.3 504 615 80.5 2.2 10.0* (7.5–13.4) 241.1* <0.001 1
Logistic regression was used to compare the prevalence of the comorbid disorder in respondents with IED to that in respondents without IED. All analyses control for participants’ age, sex, education (in country-specific quartiles) and country of origin.
Bold values highlight the results for disorder classes (i,e. groups of disorders).
aNominator N (number of participants reporting the outcome).
bDenominator N (number of participants asked the question).
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Table 3. Lifetime prevalence of comorbid disorders in respondents with various IED subtypes, compared to those without IED
Type of IED





b OR (95% CI) n1
a n2
b OR (95% CI) n1
a n2
b OR (95% CI) n1
a n2
b OR (95% CI) n1
a n2
b OR (95% CI) Wald X2 p-value df
Agoraphobia (with
or without panic)
1203 44 651 41 332 5.0* (3.3–7.7) 5 51 4.6* (1.4–14.6) 4 70 3.6* (1.3–10.3) 3 110 0.8 (0.2–2.8) 7 52 4.9* (2.0–12.0) 90.6* <0.001 5
Generalised anxiety
disorder




1200 44 651 48 332 5.3* (3.5–8.1) 9 51 7.7* (3.1–19.5) 4 70 1.6 (0.6–4.5) 9 110 2.9* (1.3–6.4) 7 52 4.5* (1.7–11.6) 101.5* <0.001 5
Post-traumatic
stress disorder
1889 38 244 60 296 5.5* (4.0–7.8) 11 45 5.4* (2.5–11.5) 9 60 3.7* (1.8–7.5) 12 99 3.5* (1.6–7.4) 8 47 4.8* (1.7–13.5) 149.4* <0.001 5
Separation anxiety
disorder
2057 26 309 76 248 4.6* (3.3–6.4) 11 41 4.5* (1.8–11.1) 11 44 5.7* (2.7–11.9) 17 65 3.7* (2.0–7.0) 8 35 3.0* (1.3–6.9) 162.0* <0.001 5
Social phobia 2533 44 651 84 332 5.1* (3.7–7.1) 15 51 4.7* (2.1–10.3) 13 70 4.2* (1.9–9.4) 14 110 2.7* (1.2–6.2) 19 52 13.3* (7.0–25.1) 197.3* <0.001 5
Specific phobia 4560 38 698 92 299 4.1* (3.0–5.7) 20 50 5.8* (2.9–11.4) 13 60 1.9 (0.9–4.2) 17 83 1.7 (0.9–3.2) 11 41 3.4* (1.4–8.3) 129.0* <0.001 5
Any anxiety
disorder




7936 44 651 109 332 2.9* (2.0–4.1) 15 51 2.6* (1.3–5.3) 21 70 2.8* (1.3–6.4) 26 110 1.8* (1.1–3.1) 19 52 4.1* (2.0–8.4) 65.1* <0.001 5
Bipolar disorder
(broad)
1188 38 698 62 299 6.9* (5.0–9.6) 11 50 10.0* (4.5–22.5) 7 60 3.7* (1.5–8.9) 11 83 3.9* (1.8–8.5) 7 41 11.3* (3.2–39.9) 210.7* <0.001 5
Any mood disorder 9124 44 651 171 332 4.9* (3.7–6.6) 26 51 6.0* (3.0–11.8) 28 70 3.4* (1.6–7.0) 37 110 2.2* (1.4–3.5) 26 52 7.9* (2.9–21.4) 158.1* <0.001 5




436 17 105 10 141 2.5* (1.4–4.5) 1 23 1.1 (0.2–8.3) 3 29 7.3* (2.1–25.8) 1 40 2.0 (0.3–14.7) 2 21 4.8* (1.0–22.7) 22.7* <0.001 5
Any eating disorder 598 17 105 16 141 3.3* (1.8–6.0) 4 23 7.6* (2.4–24.6) 4 29 8.3* (2.8–24.6) 2 40 2.5 (0.6–10.5) 3 21 5.5* (1.5–20.8) 43.1* <0.001 5
Any internalising
disorder
13 487 44 651 249 332 9.0* (6.5–12.5) 36 51 6.0* (2.5–14.6) 47 70 7.8* (4.2–14.4) 64 110 4.2* (2.4–7.3) 39 52 14.8* (5.3–41.8) 287.9* <0.001 5
Attention deficit
disorder
589 25 952 42 231 5.7* (3.3–9.8) 7 38 4.9* (1.8–13.3) 6 48 4.3* (1.8–10.0) 5 63 3.5 (0.9–14.1) 1 32 1.5 (0.2–10.6) 54.1* <0.001 5
Conduct disorder 652 21 666 55 212 7.2* (4.6–11.3) 10 35 5.9* (2.5–13.8) 5 37 2.9* (1.1–7.5) 10 63 5.8* (2.5–13.5) 4 29 5.1* (1.7–15.5) 121.2* <0.001 5
Oppositional defiant
disorder
775 18 634 58 186 7.0* (4.2–11.6) 11 34 6.9* (2.9–15.9) 7 34 5.1* (2.2–11.9) 12 48 5.8* (2.8–12.3) 0 26 0.0* (0.0–0.0) 12 680.0* <0.001 5
Any disruptive
behaviour disorder
1540 28 406 100 246 9.1* (6.2–13.3) 14 39 4.1* (1.8–9.1) 13 49 5.8* (3.1–10.9) 19 75 6.7* (3.2–14.4) 4 34 1.9 (0.6–6.0) 179.3* <0.001 5
Alcohol abuse 4136 42 226 132 305 7.4* (5.5–9.9) 12 48 2.0 (0.9–4.5) 21 62 4.3* (2.2–8.5) 34 102 6.9* (3.7–13.0) 9 48 2.5* (1.1–5.3) 240.5* <0.001 5
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only made once other mental disorders and personality disorders
that could better explain the aggressive behaviour have been
ruled out. Of the five disorders found most likely to be comorbid
with IED in this study (GAD, bipolar disorder, CD, ODD and alco-
hol dependence), the latter four are either defined by or strongly
associated with aggressive behaviour (Jensen et al., 2007). This
study did exclude from IED diagnosis those who reported that
their anger attacks occurred exclusively in the context of depres-
sion, substance intoxication or mania, but those with concurrent
CD or ODD were not similarly excluded. Moreover, personality
disorders were not assessed in enough of the surveys that also
assessed IED to assess overlap. As previously reported (Scott
et al., 2016), a small proportion of the IED sample admitted to pur-
posely torturing or injuring an animal, or arson, within the prior 12
months, so it is possible that these individuals may be more appro-
priately classified as personality disordered (or CD) than IED.
Some researchers have chosen to deal with the difficulty of dif-
ferentiating between IED and bipolar disorder by excluding peo-
ple with a lifetime history of bipolar disorder from the IED
sample (Kulper et al., 2015; Rynar and Coccaro, 2018; Fahlgren
et al., 2019). It is unclear why the same theoretical concern
does not apply to some of the other comorbid disorders, and if
we were to remove all those with lifetime comorbidities associated
with impulsive aggression from the group classified with IED we
would end up with a much smaller group. It is interesting in this
regard to consider the small subgroup of those diagnosed with
IED in this study who reported no comorbid disorders. This is
a ‘pure’ IED group therefore, whose impulsive anger cannot be
attributed to another disorder. We found this group to have
much less impairment and suicidality than the bigger group
with comorbid disorders. This could suggest that the ramifica-
tions of IED for the individual and society are better captured
by its comorbid disorders and that the diagnosis of IED per se
offers little additional information. On the other hand, comorbid-
ity has generally been found to be a marker for severity of psycho-
pathology, and in the case of IED, it may signify that most
sufferers experience such persistent tendencies towards irritable
temperament and impulsive anger that these tendencies manifest
across several diagnostic boundaries.
Our IED behavioural subtypes were defined on the basis of self-
reported behaviour and limited to what was available in the CIDI
assessment. The subtypes have not been clinically validated and
nor was the diagnosis of IED included in the clinical reappraisal
studies conducted as part of the World Mental Health surveys
(Haro et al., 2006). The fact that we did not find variation in suicidal
behaviour, or functional impairment, across the five behavioural
subtypes suggests that they may not capture clinically useful distinc-
tions. It is noteworthy that the two further approaches to subtyping
we report herein did result in significant findings related to suicide.
That is, we differentiated between those with and without any life-
time comorbidity, and between those engaging in more or less vio-
lent attacks, and we did find suicidality significantly higher among
those with comorbidity, and among those engaging in more violent
anger attacks that resulted in the victims requiring medical atten-
tion. From a clinical point of view therefore, these distinctions rather
than the behavioural subtyping distinctions may prove more useful.
The findings of this study are inconsistent with prior clinical
studies in several respects. Coccaro et al. who have led the clinical
research on IED, have conducted a series of studies in which par-
ticipants responding to advertisements seeking individuals with
anger difficulties were diagnosed with DSM-5 IED, other mental
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reported greater functional impairment than the ‘other mental
disorder’ comparison group (Kulper et al., 2015; Rynar and
Coccaro, 2018), whereas our finding of 39.8% of those with IED
reporting severe impairment is lower than the corresponding pro-
portion reported for other mental disorders (Scott et al., 2018). In
these and in other clinical studies from the same group (Fahlgren
et al., 2019; Fanning et al., 2019), IED-associated comorbidity was
dominated by internalising disorders, in contrast to our finding
that comorbidity was at least equally if not more likely to be
with externalising disorders. It is notable that in all of the clinical
studies females comprised around half of the IED sample (in con-
trast to our male-dominated general population sample); this
raises the possibility that the clinical findings are influenced by
gender, help-seeking or other selection biases.
Our findings illustrate the heterogeneity within the diagnostic
category captured by the WMH-CIDI for IED. Depending on
Table 4. Lifetime prevalence of comorbid disorders in respondents who have or have never hurt someone so badly they needed medical attention
Did not need medical attention Needed Medical attention Statistical test
Comorbid disorder n1
a n2
b %c S.E. n1
a n2





39 429 8.5 1.5 19 171 9.0 2.3 1.0 (0.5–2.3) 0.0 0.966 1
Generalised anxiety
disorder
94 429 21.0 2.4 32 171 22.2 4.3 1.2 (0.7–2.0) 0.3 0.585 1
Panic disorder (with or
without agoraphobia)
52 429 9.8 1.5 23 171 9.1 2.4 1.2 (0.6–2.5) 0.3 0.612 1
Post-traumatic stress
disorder
67 383 16.3 2.0 32 150 17.8 3.7 1.3 (0.6–2.8) 0.6 0.442 1
Separation anxiety disorder 85 308 26.8 2.7 37 118 33.5 5.0 1.2 (0.7–2.0) 0.3 0.570 1
Social phobia 103 429 24.2 2.4 41 171 23.6 4.1 1.1 (0.6–2.0) 0.2 0.639 1
Specific phobia 108 375 26.5 2.2 44 147 29.0 4.7 1.1 (0.7–1.9) 0.3 0.608 1
Any anxiety disorder 235 429 54.0 2.9 101 171 59.3 4.8 1.5 (0.9–2.4) 2.6 0.104 1
Major depression or
dysthymia (hierarchical)
138 429 27.3 3.0 49 171 26.1 3.9 1.0 (0.6–1.6) 0.0 0.982 1
Bipolar disorder (broad) 59 375 15.4 2.4 39 147 24.1 4.3 1.8* (1.0–3.3) 4.0* 0.045 1
Any mood disorder 197 429 40.5 3.4 88 171 44.5 4.7 1.4 (0.9–2.2) 1.7 0.189 1
Bulimia nervosa 9 179 5.3 1.9 3 68 2.7 2.5 0.1 (0.0–3.6) 1.5 0.221 1
Binge eating disorder
(hierarchical)
11 179 6.2 2.3 6 68 7.9 2.7 1.1 (0.3–4.3) 0.0 0.874 1
Any eating disorder 20 179 11.5 2.9 9 68 10.6 3.7 0.6 (0.2–2.4) 0.4 0.514 1
Any internalising disorder 302 429 67.5 2.9 125 171 69.1 4.9 1.2 (0.7–2.0) 0.5 0.483 1
Attention deficit disorder 37 282 13.9 2.5 23 122 19.3 4.8 1.2 (0.6–2.4) 0.2 0.689 1
Conduct disorder 45 261 16.3 2.2 38 109 41.6 6.9 3.1* (1.5–6.4) 9.5* 0.002 1
Oppositional defiant
disorder
52 228 21.7 3.1 35 95 38.3 6.1 2.0* (1.0–3.9) 4.4* 0.036 1
Any disruptive behaviour
disorder
88 304 29.0 2.8 60 130 48.9 5.8 2.7* (1.5–4.8) 12.0* <0.001 1
Alcohol abuse 127 395 31.9 3.0 74 155 52.0 4.6 2.3* (1.5–3.7) 13.1* <0.001 1
Alcohol dependence 69 395 16.7 2.1 44 155 29.0 5.3 2.3* (1.3–4.1) 7.8* 0.005 1
Drug abuse 57 380 13.6 2.2 43 150 26.4 4.3 2.7* (1.5–4.7) 11.9* <0.001 1
Drug dependence 35 380 8.7 1.6 21 150 13.0 3.2 1.9 (0.9–3.8) 3.1 0.079 1
Any substance use
disorder
144 395 35.9 3.2 84 155 59.0 4.8 2.6* (1.6–4.2) 15.2* <0.001 1
Any externalising disorder 189 429 44.2 3.0 105 171 64.8 4.7 2.6* (1.6–4.4) 13.4* <0.001 1
Any disorder 344 429 77.6 2.8 148 171 87.7 3.0 2.0 (1.0–4.1) 3.4 0.064 1
Logistic regression was used to compare the prevalence of the comorbid disorder. All analyses control for participants’ age, sex, education (in country-specific quartiles) and country of origin.
Bold values highlight the results for disorder classes (i,e. groups of disorders).
aNominator N (number of participants reporting the outcome).
bDenominator N (number of participants asked the question).
cPercentages are based on weighted data.
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how the impulsive anger manifested (in particular, whether it
resulted in harm to others), type of comorbidity varied consider-
ably. This variation in comorbidity patterning as a function of
whether the anger attacks result in harm to others suggests that
the present DSM-5 diagnostic criteria, which allow IED to be
defined by either high frequency-less destructive acts or low
frequency-more destructive acts, will similarly encompass a popu-
lation that varies substantially in lifetime comorbidity. In this
regard, our study findings are consistent with one study from
Coccaro’s group, which found that comorbidity patterning varied
by DSM-5 IED subtypes (verbal aggression only, physical aggres-
sion only, or both) (Look et al., 2015). The implications of this
heterogeneity in comorbidity for IED as a diagnostic entity are
unclear. While it is the case that several mental disorders are char-
acterised by phenotypic subtypes, the findings presented here sug-
gest that these IED behavioural subtypes are characterised by very
different patterns of psychopathology over the life course, such
that the disorder becomes difficult to classify as internalising or
externalising (de Jonge et al., 2018).
In conclusion, the findings of this study point to a disparity
between the comorbidity patterning and impairment associated
with IED in population v. clinical studies. This disparity, together
with the marked heterogeneity that characterises the diagnostic
entity of IED, suggests that it is a disorder that requires much
greater research.
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Suicidality variable n1
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aNominator N (number of participants reporting the outcome).
bDenominator N (number of participants asked the question).
cPercentages are based on weighted data.
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